74788-82-2 Usage
Description
2,6-Dimethylbenzylamine is an organic compound with the chemical formula C9H13N. It is a colorless to pale yellow liquid with a characteristic amine-like odor. 2,6-Dimethylbenzylamine is known for its role as an intermediate in the synthesis of various organic compounds, particularly flavin derivatives.
Uses
Used in Pharmaceutical Industry:
2,6-Dimethylbenzylamine is used as an intermediate in the synthesis of flavin derivatives for therapeutic use as anti-infective agents. These flavin derivatives have potential applications in the development of new drugs to combat infections caused by bacteria, viruses, and other pathogens.
Check Digit Verification of cas no
The CAS Registry Mumber 74788-82-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,7,8 and 8 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 74788-82:
(7*7)+(6*4)+(5*7)+(4*8)+(3*8)+(2*8)+(1*2)=182
182 % 10 = 2
So 74788-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N/c1-7-4-3-5-8(2)9(7)6-10/h3-5H,6,10H2,1-2H3
74788-82-2Relevant articles and documents
Compounds for the treatment of metabolic disorders
-
Page/Page column 106, (2016/03/12)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
Compounds for the treatment of metabolic disorders
-
, (2008/06/13)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
Novel isoxazole and isoxazoline compounds with anticonvulsant activity process for their preparation and therapeutic composition containing them
-
, (2008/06/13)
The object of the invention are anticonvulsant heterocyclic compounds of general formula: STR1 in which R1 and R2 is each selected from C1 -C4 alkyl, phenyl, benzyl, trifluoromethyl or halogen, R3 is